A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
Researchers have found that cancer patients undergoing treatment are more likely to believe COVID-19 related misinformation than those without a history of cancer.
Studying tags, or modifications to cell-free DNA , may lead to a better understanding of how to assess, and treatment approaches for cancer and other diseases.
1672397318_80X80.jpg)
